Trademark: 88570163
Status Date
Monday, September 18, 2023
Filing Date
Wednesday, August 7, 2019
Published for Opposition
Tuesday, June 23, 2020
Abandoned Date
Monday, September 18, 2023
9 Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring analytes in interstitial fluids, blood, plasma, or other biological fluids; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring chronic health conditions; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring analytes in the human body and automatically or semi-automatically delivering medications to control the analyte concentration to be within a desired range; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring chronic health conditions and automatically or semi-automatically delivering medications to control or treat the chronic health conditions; Downloadable software in the nature of mobile applications and hardware for use in the acquisition, processing, analysis, presentation, storage, and transmission of medical and physiological data, namely, data about analytes and chronic health conditions; Downloadable software in the nature of mobile applications and hardware for use to automatically or semi-automatically deliver medications to control an individual's analyte concentration to be within a desired range or otherwise control or treat an individual's chronic health condition
10 Medical devices used to monitor analytes in interstitial fluids, blood, plasma, and other biological fluids; Medical devices used to monitor chronic health conditions, namely, devices for monitoring glucose for medical purposes, analytes for renal function, respiratory state, pulmonary function, heart disease, cancer and psychotropic medications; Medical devices, namely, patient sensors inserted into the human body and used to monitor analytes in the human body or monitor a person's chronic health conditions, namely, for monitoring glucose for medical purposes, analytes for renal function, respiratory state and pulmonary function; Medical devices, namely, patient sensors used to monitor analytes in the human body and patient sensors to manage diabetes by automatically or semi-automatically delivering measured amounts of medications subcutaneously over time to control the analyte concentration to be within a desired range; Medical devices, namely, patient sensors used to monitor glucose, oxygen, creatinine, urea, medication, sodium, potassium, or chloride concentrations and patient sensors to manage chronic health conditions by automatically or semi-automatically delivering measured amounts of medications subcutaneously to control or treat an individual's chronic health conditions; Analyte and chronic health condition monitor accessories being devices for monitoring glucose for medical purposes, analytes for renal function, respiratory state, pulmonary function, and cancer, namely, transmitters, receivers, and medical sensor insertion devices
42 Providing temporary use of on-line non-downloadable software for use in the acquisition, processing, analysis, presentation, storage, and transmission of medical and physiological data, namely, data about analytes and chronic health conditions
The mark consists of three shaded, stylized vertical wave designs, arranged from left to right from smallest to largest. The wave designs are bordered by a single line, incomplete circle.
Color is not claimed as a feature of the mark.
Sep 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 18, 2023
Abandonment - No Use Statement Filed
Mar 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2023
Sou Extension 5 Granted
Feb 17, 2023
Sou Extension 5 Filed
Mar 3, 2023
Case Assigned To Intent To Use Paralegal
Feb 17, 2023
Sou Teas Extension Received
Aug 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2022
Sou Extension 4 Granted
Aug 17, 2022
Sou Extension 4 Filed
Aug 17, 2022
Sou Teas Extension Received
Jan 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 6, 2022
Sou Extension 3 Granted
Jan 6, 2022
Sou Extension 3 Filed
Jan 6, 2022
Sou Teas Extension Received
Aug 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2021
Sou Extension 2 Granted
Aug 17, 2021
Sou Extension 2 Filed
Aug 17, 2021
Sou Teas Extension Received
Feb 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 17, 2021
Sou Extension 1 Granted
Feb 17, 2021
Sou Extension 1 Filed
Feb 17, 2021
Sou Teas Extension Received
Aug 18, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 23, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 23, 2020
Published For Opposition
Jun 3, 2020
Notification Of Notice Of Publication E-Mailed
May 18, 2020
Assigned To Lie
May 12, 2020
Approved For Pub - Principal Register
May 12, 2020
Examiner's Amendment Entered
May 12, 2020
Notification Of Examiners Amendment E-Mailed
May 12, 2020
Examiners Amendment E-Mailed
May 12, 2020
Examiners Amendment -Written
May 6, 2020
Teas/Email Correspondence Entered
May 6, 2020
Correspondence Received In Law Office
May 6, 2020
Teas Response To Office Action Received
Nov 7, 2019
Notification Of Non-Final Action E-Mailed
Nov 7, 2019
Non-Final Action E-Mailed
Nov 7, 2019
Non-Final Action Written
Nov 6, 2019
Assigned To Examiner
Aug 27, 2019
Notice Of Design Search Code E-Mailed
Aug 24, 2019
New Application Office Supplied Data Entered
Aug 10, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
